Agenus (AGEN) Change in Account Payables (2010 - 2026)
Agenus' (AGEN) quarterly Change in Account Payables came in at -$11.9 million in Q1 2026, down 549.66% year-on-year from $2.6 million in Q1 2025, and down 255.69% quarter-over-quarter from -$3.3 million in Q4 2025.
Agenus (AGEN) Change in Account Payables (2010 - 2026) Analysis & Trends
Agenus' Change in Account Payables history runs 17 years deep, the most recent figure standing at -$11.9 million for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 549.66% year-over-year to -$11.9 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 41.66% decrease from a year earlier, with the FY2025 full-year figure at $23.5 million, up 1067.41% from the prior year.
- Change in Account Payables declined to -$11.9 million in Q1 2026 per AGEN's latest filing, from -$3.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $20.5 million in Q4 2023 and bottomed at -$11.9 million in Q1 2026.
- The 5-year median for Change in Account Payables is $2.0 million (2023), against an average of $2.4 million.
- Across the five-year window, Change in Account Payables surged 3095.6% in 2022 and plunged 822.75% in 2023, its largest moves.
- Year by year, Change in Account Payables stood at $5.2 million in 2022, then soared by 296.72% to $20.5 million in 2023, then fell by 23.26% to $15.7 million in 2024, then tumbled by 121.28% to -$3.3 million in 2025, then slumped by 255.69% to -$11.9 million in 2026.
- Per Business Quant, the three latest AGEN Change in Account Payables figures stand at -$11.9 million (Q1 2026), -$3.3 million (Q4 2025), and $14.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | -11.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.88 Mn |
| Mar 31, 2026 | -11.88 Mn |
| Dec 31, 2025 | -3.34 Mn |
| Dec 31, 2025 | -3.34 Mn |
| Sep 30, 2025 | 14.13 Mn |
| Sep 30, 2025 | 14.13 Mn |
| Jun 30, 2025 | 10.06 Mn |
| Jun 30, 2025 | 10.06 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 15.70 Mn |
| Dec 31, 2024 | 15.70 Mn |
| Sep 30, 2024 | -4.96 Mn |
| Sep 30, 2024 | -4.96 Mn |
| Jun 30, 2024 | 2.02 Mn |
| Jun 30, 2024 | 2.02 Mn |
| Mar 31, 2024 | -10.73 Mn |
| Mar 31, 2024 | -10.73 Mn |
| Dec 31, 2023 | 20.45 Mn |
| Dec 31, 2023 | 20.45 Mn |